Enhancing adoptive T cell transfer therapies: Novel treatments through IL-12 CD8 T cell priming and adjunctive use of a histone deacetylase inhibitor

Dominique N. Lisiero(University of California, Los Angeles)

eScholarship (California Digital Library)

January 1, 2012

Cited by 0

Related Papers

Enhanced Sensitivity to IL-2 Signaling Regulates the Clinical Responsiveness of IL-12–Primed CD8+ T Cells in a Melanoma Model

|The Journal of Immunology|2011|25